About this trial
Study: observational prospective clinical study. Study population: Subjects over 55 years old with drusen secondary to intermediate AMD.
Recruitment: at the Medical Retinal Consultation from the Ophthalmology Department of CHULC.
Primary outcome: Identifying imaging predictors of iAMD progression.
Eligibility criteria
Qualifiers
To verify the existence of drusen secondary to intermediate AMD; Soft, cuticular and reticular pseudo-drusen will be considered.
Accept and sign the consent.
Disqualifiers
Patients are excluded if it is not possible to obtain good quality CFP, SD-OCT, OCT-A images, if refractive error is ≥±6D or if there is any evidence of accumulation of extracellular fluid, haemorrhage, exudates or fibrosis.
Additional exclusion criteria included any history of retinal surgery including laser treatment, signs of diabetic retinopathy, history of retinal vascular occlusion, history of anti-VEGF treatment in the study eye or any signs or history of hereditary retinal or macular dystrophy.
Trial design
Treatments tested in this trial
- Orthoptic assessment (Outcome measure)
Treatment groups
Sponsors and collaborators
Universidade Nova de Lisboa
Lead sponsor
iNOVA4Health, NOVA Medical School|Faculdade de Ciências Médicas, NMS|FCM, UNL
Collaborator
Centro Hospitalar de Lisboa Central
Collaborator
Centro Hospitalar De São João, E.P.E.
Collaborator